147 related articles for article (PubMed ID: 16763214)
1. Tissue-transglutaminase contributes to neutrophil granulocyte differentiation and functions.
Balajthy Z; Csomós K; Vámosi G; Szántó A; Lanotte M; Fésüs L
Blood; 2006 Sep; 108(6):2045-54. PubMed ID: 16763214
[TBL] [Abstract][Full Text] [Related]
2. Tissue transglutaminase contributes to the all-trans-retinoic acid-induced differentiation syndrome phenotype in the NB4 model of acute promyelocytic leukemia.
Csomós K; Német I; Fésüs L; Balajthy Z
Blood; 2010 Nov; 116(19):3933-43. PubMed ID: 20739659
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-κB activation.
Jambrovics K; Uray IP; Keresztessy Z; Keillor JW; Fésüs L; Balajthy Z
Haematologica; 2019 Mar; 104(3):505-515. PubMed ID: 30237268
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils.
Rose DM; Sydlaske AD; Agha-Babakhani A; Johnson K; Terkeltaub R
Arthritis Rheum; 2006 Oct; 54(10):3363-71. PubMed ID: 17009310
[TBL] [Abstract][Full Text] [Related]
5. Gp91phox contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells.
Chamseddine AH; Miller FJ
Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2284-9. PubMed ID: 12855428
[TBL] [Abstract][Full Text] [Related]
6. Role of transglutaminase 2 in PAC
Algarni AS; Hargreaves AJ; Dickenson JM
Biochem Pharmacol; 2017 Mar; 128():55-73. PubMed ID: 28065858
[TBL] [Abstract][Full Text] [Related]
7. Molecular and functional characterization of Hv1 proton channel in human granulocytes.
Petheo GL; Orient A; Baráth M; Kovács I; Réthi B; Lányi A; Rajki A; Rajnavölgyi E; Geiszt M
PLoS One; 2010 Nov; 5(11):e14081. PubMed ID: 21124855
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of functional responses in differentiated myeloid cell lines reveals EPRO cells as a valid model of murine neutrophil functional activation.
Gaines P; Chi J; Berliner N
J Leukoc Biol; 2005 May; 77(5):669-79. PubMed ID: 15673544
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase down-regulates the dimerization of epidermal growth factor receptor in rat perivenous and periportal hepatocytes.
Maruko A; Ohtake Y; Katoh S; Ohkubo Y
Cell Prolif; 2009 Oct; 42(5):647-56. PubMed ID: 19614676
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Oh K; Park HB; Seo MW; Byoun OJ; Lee DS
Clin Immunol; 2012 Nov; 145(2):122-32. PubMed ID: 23001131
[TBL] [Abstract][Full Text] [Related]
11. Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase.
Mishra S; Murphy LJ
J Biol Chem; 2004 Jun; 279(23):23863-8. PubMed ID: 15069073
[TBL] [Abstract][Full Text] [Related]
12. Interaction between p21-activated protein kinase and Rac during differentiation of HL-60 human promyelocytic leukemia cell induced by all-trans-retinoic acid.
Nisimoto Y; Ogawa H
Eur J Biochem; 2002 May; 269(10):2622-9. PubMed ID: 12027902
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapy.
Meshram DD; Pike CVS; Coussons PJ
Eur J Pharmacol; 2017 Nov; 815():332-342. PubMed ID: 28943101
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size.
Boisvert WA; Rose DM; Boullier A; Quehenberger O; Sydlaske A; Johnson KA; Curtiss LK; Terkeltaub R
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):563-9. PubMed ID: 16410462
[TBL] [Abstract][Full Text] [Related]
15. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
[TBL] [Abstract][Full Text] [Related]
16. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
17. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway.
Kim WS; Kim H; Jeong EM; Kim HJ; Lee ZH; Kim IG; Kim HH
Sci Rep; 2017 Sep; 7(1):10626. PubMed ID: 28878266
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminase activity regulates atherosclerotic plaque composition at locations exposed to oscillatory shear stress.
Matlung HL; Neele AE; Groen HC; van Gaalen K; Tuna BG; van Weert A; de Vos J; Wentzel JJ; Hoogenboezem M; van Buul JD; VanBavel E; Bakker EN
Atherosclerosis; 2012 Oct; 224(2):355-62. PubMed ID: 22921425
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid-induced tissue transglutaminase and apoptosis in vascular smooth muscle cells.
Ou H; Haendeler J; Aebly MR; Kelly LA; Cholewa BC; Koike G; Kwitek-Black A; Jacob HJ; Berk BC; Miano JM
Circ Res; 2000 Nov; 87(10):881-7. PubMed ID: 11073883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
